2010•Zhongguo Yike Daxue xuebaoRequires access

The effects of SH3GL2 gene on proliferation, apoptosis and chemotherapeutic sensibility in laryngeal cancer Hep2 cell.

Chao Shang, Yan Guo, Li Wei, FU Wei-neng, Kailai Sun

Open publisher page 0 citations

Abstract

Objective To investigate the effects of SH3GL2 on apoptosis,proliferation and sensitivity to cis-diamminedichloroplatinum (DDP)in Hep2 cell. Methods After pcDNA3.1-SH3GL2 was constructed and transfected into Hep2 cell,the proliferation of the transfected cells was determined by methyl thiazolyl tetrazolium (MTT)and the apoptosis by flow cytometry with the treatment of DDP. Results The expression of SH3GL2 was increased after Hep2 cells were transfected with pcDNA3.1-SH3GL2,which was successfully constructed. Compared with control,the proliferation of transfectant cells was inhibited significantly (P 0.05),and significant increase of their apoptosis was observed(P 0.05). Compared with DDP-treated group,the proliferation was more significantly inhibited(P 0.05),and more significant increase of apoptosis was found in pcDNA3.1-SH3GL2-transfected cells (P 0.05). Conclusion SH3GL2 gene can inhibit proliferation and increase apoptosis of Hep2 cell,and can increase the sensitivity to DDP.

About this research paper

What this paper is about

Objective To investigate the effects of SH3GL2 on apoptosis,proliferation and sensitivity to cis-diamminedichloroplatinum (DDP)in Hep2 cell. Methods After pcDNA3.1-SH3GL2 was constructed and transfected into Hep2 cell,the proliferation of the transfected cells was determined by methyl thiazolyl tetrazolium (MTT)and the apoptosis by flow cytometry with the treatment of DDP. Results The expression of SH3GL2 was increased after Hep2 cells were transfected with pcDNA3.1-SH3GL2,which was successfully constructed. Compared with control,the proliferation of transfectant cells was inhibited significantly (P 0.05),and significant increase of their apoptosis was observed(P 0.05). Compared with DDP-treated group,the proliferation was more significantly inhibited(P 0.05),and more significant increase of apoptosis was found in pcDNA3.1-SH3GL2-transfected cells (P 0.05). Conclusion SH3GL2 gene can inhibit proliferation and increase apoptosis of Hep2 cell,and can increase the sensitivity to DDP.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the effects of SH3GL2 on apoptosis,proliferation and sensitivity to cis-diamminedichloroplatinum (DDP)in Hep2 cell. Methods After pcDNA3.1-SH3GL2 was constructed and transfected into Hep2 cell,the proliferation of the transfected cells was determined by methyl thiazolyl tetrazolium (MTT)and the apoptosis by flow cytometry with the treatment of DDP. Results The expression of SH3GL2 was increased after Hep2 cells were transfected with pcDNA3.1-SH3GL2,which was successfully constructed. Compared with control,the proliferation of transfectant cells was inhibited significantly (P 0.05),and significant increase of their apoptosis was observed(P 0.05). Compared with DDP-treated group,the proliferation was more significantly inhibited(P 0.05),and more significant increase of apoptosis was found in pcDNA3.1-SH3GL2-transfected cells (P 0.05). Conclusion SH3GL2 gene can inhibit proliferation and increase apoptosis of Hep2 cell,and can increase the sensitivity to DDP.

Key concepts: Apoptosis, Transfection, Flow cytometry, Cell growth, Molecular biology, Cell, MTT assay, Growth inhibition

Related papers

Back to paper searchBrowse research topicsOriginal source
The effects of SH3GL2 gene on proliferation, apoptosis and chemotherapeutic sensibility in laryngeal cancer Hep2 cell. — Research Paper | ScholarLens